Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00082472
Status:
UNKNOWN
Last Update Posted:
2006-04-18
First Post:
2004-05-11
Brief Title:
Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma NSCLC
Sponsor:
Zivena
Organization:
Zivena
Organization Data
Organization:
Zivena
Class:
INDUSTRY
Study ID:
Dox-2a-07
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Zivena
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None